Q2 2023 Capricor Therapeutics Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics second-quarter 2023 financial results and corporate update call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to our host, Mr. AJ Bergmann, Capricor's Chief Financial Officer.
Thank you and good afternoon, everyone. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety, and intended utilization of our product candidates; our future research and development plans, including our anticipated conduct and timing of preclinical and clinical studies; plans to present or report additional data; our plans regarding regulatory filings; potential regulatory developments regarding our product candidates; manufacturing capabilities; potential milestone payments and other possible uses of existing cash and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |